Pre-made Igovomab benchmark antibody (Radiolabelled antibody, anti-MUC16 therapeutic antibody, Anti-CA125 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-made Igovomab benchmark antibody (Radiolabelled antibody, anti-MUC16 therapeutic antibody, Anti-CA125 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Indium (111In) igovomab (trade name Indimacis-125) was a mouse monoclonal antibody for the diagnosis of ovarian cancer.[citation needed]

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-861-1mg	1mg	3090
GMP-Bios-INN-861-10mg	10mg	Inquiry
GMP-Bios-INN-861-100mg	100mg	Inquiry
GMP-Bios-INN-861-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Igovomab Biosimilar, Radiolabelled Antibody, Anti-Muc16 Antibody: Anti-CA125 therapeutic antibody
INN Name	Igovomab
Target	MUC16
Format	Radiolabelled antibody
Derivation	Mus musculus
Species Reactivity	human
CH1 Isotype	F(ab')2 - G1 - nd
VD LC	F(ab')2 - G1 - nd
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	CIS Bio international (Bagnols/C France)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0